Atlas Legacy Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
4,361
+1,260
+41% +$294K 0.16% 96
2026
Q1
$756K Sell
3,101
-1,049
-25% -$244K 0.14% 106
2025
Q4
$872K Buy
4,150
+49
+1% +$9.69K 0.15% 99
2025
Q3
$760K Buy
4,101
+1,366
+50% +$234K 0.15% 99
2025
Q2
$418K Buy
2,735
+463
+20% +$71.2K 0.09% 130
2025
Q1
$377K Buy
2,272
+535
+31% +$83.7K 0.1% 126
2024
Q4
$251K Buy
+1,737
New +$269K 0.06% 156

Other funds holding JNJ

Atlas Legacy Advisors's JNJ Position: Q2 2026 in Review

Atlas Legacy Advisors increased its Johnson & Johnson (JNJ) stake by 41% in Q2 2026, buying an estimated $294K and bringing the position to 4,361 shares worth $1.07M. The position accounts for 0.16% of the portfolio, ranked #96.

Atlas Legacy Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Atlas Legacy Advisors held 4,361 shares of Johnson & Johnson worth $1.07M as of Q2 2026.
  • Atlas Legacy Advisors bought 1,260 Johnson & Johnson shares in Q2 2026, an estimated $294K.
  • Johnson & Johnson made up 0.16% of Atlas Legacy Advisors's portfolio in Q2 2026, its #96 holding.
  • Atlas Legacy Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Atlas Legacy Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.